Retirement Planning Company of New England’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
1,789
-11
| -0.6% | -$1.39K | 0.1% | 214 |
|
|
2025
Q1 | $230K | Sell |
1,800
-25
| -1% | -$3.2K | 0.11% | 203 |
|
|
2024
Q4 | $241K | Sell |
1,825
-6
| -0.3% | -$794 | 0.12% | 198 |
|
|
2024
Q3 | $267K | Sell |
1,831
-71
| -4% | -$10.3K | 0.13% | 183 |
|
|
2024
Q2 | $261K | Buy |
1,902
+6
| +0.3% | +$824 | 0.14% | 175 |
|
|
2024
Q1 | $260K | Sell |
1,896
-68
| -3% | -$9.33K | 0.14% | 183 |
|
|
2023
Q4 | $267K | Sell |
1,964
-49
| -2% | -$6.66K | 0.12% | 180 |
|
|
2023
Q3 | $246K | Sell |
2,013
-526
| -21% | -$64.3K | 0.14% | 159 |
|
|
2023
Q2 | $322K | Sell |
2,539
-31
| -1% | -$3.94K | 0.19% | 149 |
|
|
2023
Q1 | $332K | Sell |
2,570
-52
| -2% | -$6.72K | 0.2% | 148 |
|
|
2022
Q4 | $344K | Sell |
2,622
-29
| -1% | -$3.81K | 0.22% | 131 |
|
|
2022
Q3 | $310K | Sell |
2,651
-56
| -2% | -$6.55K | 0.22% | 136 |
|
|
2022
Q2 | $318K | Sell |
2,707
-75
| -3% | -$8.81K | 0.22% | 139 |
|
|
2022
Q1 | $362K | Buy |
2,782
+11
| +0.4% | +$1.43K | 0.2% | 139 |
|
|
2021
Q4 | $422K | Buy |
+2,771
| New | +$422K | 0.21% | 133 |
|